Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
暂无分享,去创建一个
D. Herrero-Martín | S. Rello-Varona | C. Rodríguez-Galindo | R. López-Alemany | Ò. M. Tirado | S. García-Monclús | Juan Huertas-Martínez | M. Sáinz-Jaspeado | L. Lagares-Tena | Olga Almacellas-Rabaiget | Silvia Mateo‐Lozano | Miguel Sáinz-Jaspeado
[1] U. Dirksen,et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Jason U Tilan,et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases , 2015, Oncotarget.
[3] C. Bourque,et al. RSK1 activation promotes invasion in nodular melanoma , 2015, Journal of Translational Medicine.
[4] A. Llombart‐Bosch,et al. Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma. , 2014, Cancer research.
[5] S. Gross,et al. Acyl-CoA synthetase 3 promotes lipid droplet biogenesis in ER microdomains , 2013, The Journal of cell biology.
[6] S. Sekaran,et al. Inhibition of Raf-MEK-ERK and Hypoxia pathways by Phyllanthus prevents metastasis in human lung (A549) cancer cell line , 2013, BMC Complementary and Alternative Medicine.
[7] J. Ramos,et al. RSK isoforms in cancer cell invasion and metastasis. , 2013, Cancer research.
[8] M. Zhang,et al. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer , 2013, Cancer biology & therapy.
[9] Zong-fang Li,et al. Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway , 2013, PloS one.
[10] O. Pardo,et al. The p90 RSK family members: common functions and isoform specificity. , 2013, Cancer research.
[11] K. Morgan,et al. Hierarchical scaffolding of an ERK1/2 activation pathway , 2013, Cell Communication and Signaling.
[12] J. Mora,et al. EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1 , 2013, PloS one.
[13] E. Gerner,et al. Caveolin‐1 is a novel regulator of K‐RAS‐dependent migration in colon carcinogenesis , 2013, International journal of cancer.
[14] J. Alonso,et al. Lysyl Oxidase Is Downregulated by the EWS/FLI1 Oncoprotein and Its Propeptide Domain Displays Tumor Supressor Activities in Ewing Sarcoma Cells , 2013, PloS one.
[15] H. Schreuder,et al. Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients , 2013, Targeted Oncology.
[16] R. Roskoski. ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.
[17] M. Maggiolini,et al. Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling. , 2012, Cellular signalling.
[18] J. Mora,et al. Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome , 2012, Pediatric blood & cancer.
[19] Philippe P Roux,et al. Regulation and function of the RSK family of protein kinases. , 2012, The Biochemical journal.
[20] J Downward,et al. An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis , 2011, Oncogene.
[21] Wendell A. Lim,et al. Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information , 2011, Science.
[22] V. Notario,et al. Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells. , 2011, International journal of oncology.
[23] V. Notario,et al. Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize , 2010, Molecular Cancer Research.
[24] A. El‐Naggar,et al. IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer , 2010, Clinical Cancer Research.
[25] Gerhard Christofori,et al. Mechanisms of Motility in Metastasizing Cells , 2010, Molecular Cancer Research.
[26] D. Herrero-Martín,et al. The molecular pathogenesis of Ewing sarcoma , 2010, Cancer biology & therapy.
[27] C. MacCarthy,et al. Caveolin‐1 promotes resistance to chemotherapy‐induced apoptosis in Ewing's sarcoma cells by modulating PKCα phosphorylation , 2010, International journal of cancer.
[28] Ole Winther,et al. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. , 2009, Molecular cell.
[29] D. Helfman,et al. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility , 2009, Proceedings of the National Academy of Sciences.
[30] Ajit Varki,et al. Molecular basis of metastasis. , 2009, The New England journal of medicine.
[31] Robert E. Brown,et al. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors. , 2009, Annals of clinical and laboratory science.
[32] Stephen L. Lessnick,et al. EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma , 2008, PloS one.
[33] M. Suvà,et al. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. , 2008, Cancer research.
[34] S. Lessnick,et al. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature , 2008, Cell cycle.
[35] David B Sacks,et al. IQGAP1 Stimulates Proliferation and Enhances Tumorigenesis of Human Breast Epithelial Cells* , 2008, Journal of Biological Chemistry.
[36] Wei Chen,et al. Differential regulation and properties of MAPKs , 2007, Oncogene.
[37] J. Blenis,et al. RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* , 2007, Journal of Biological Chemistry.
[38] J. Ban,et al. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. , 2006, Cancer research.
[39] C. Rodríguez-Galindo,et al. STAT3 is activated in a subset of the Ewing sarcoma family of tumours , 2006, The Journal of pathology.
[40] Ha-won Jeong,et al. IQGAP1 Binds Rap1 and Modulates Its Activity* , 2004, Journal of Biological Chemistry.
[41] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[42] Kazuki Nabeshima,et al. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. , 2002, Cancer letters.
[43] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[44] R. Ilaria,et al. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation , 2000, Oncogene.
[45] G. Thomas,et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.
[46] P. Picci,et al. Metalloproteinase expression and prognosis in soft tissue sarcomas. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.